Heroin, marijuana and cocaine are widely abused drugs. Their use can be readily detected by analyzing urine for the metabolites morphine (MOR), tetrahydrocannabinol (THC) or benzoylecgonine (BZC). A multiplex immunosensor is described here for detection of MOR, THC and BZC using screen printed carbon array electrodes modified with gold nanoparticles. Antibodies against MOR, THC and BZC were immobilized on eight electrodes in a sensor array simultaneously, and a competitive assay was used for the detection. The free analytes in the sample compete with bovine serum albumin-conjugated analytes for the immobilized antibodies on the sensor surface. The array is capable of detecting the three drugs simultaneously within 20-40 min. The method has a high sensitivity, with detection limits as low as 1.2, 7.0, and 8.0 pg.mL for MOR, THC and BZC, respectively. Cross reactivity testing was preformed to monitor any nonspecific binding. The results revealed good selectivity. Urine samples were spiked with the 3 drugs and tested with the multiplexed immunosensor. Recovery percentages ranged between 88 to 115%. Graphical abstract Schematic presentation of the multiplexed immunosensor for drugs of abuse,viz. tetrahydrocannabinol (THC), morphine (MOR), and benzoylecgonine (BZC)) by using an array of modified electrodes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00604-019-3646-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
CBD Versus CBDP: Comparing In Vitro Receptor-Binding Activities.
Int J Mol Sci
July 2024
Charlotte's Web, 700 Tech Court, Louisville, CO 80027, USA.
Phytocannabinoids with seven-carbon alkyl chains (phorols) have gained a lot of attention, as they are commonly believed to be more potent versions of typical cannabinoids with shorter alkyl chains. At the time of this article, cannabidiphorol (CBDP) and tetrahydrocannabiphorol (THCP) can both be purchased in the North American market, even though their biological activities are nearly unknown. To investigate their relative potency, we conducted in vitro receptor-binding experiments with CBDP (cannabinoid CB1/CB2 receptor antagonism, serotonin 5HT-1A agonism, dopamine D2S (short form) agonism, and mu-opioid negative allosteric modulation) and compared the observed activity with that of CBD.
View Article and Find Full Text PDFChronic Δ9-tetrahydrocannabinol treatment has dose-dependent effects on open field exploratory behavior and [H] SR141716A receptor binding in the rat brain.
Life Sci
August 2023
Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, United States of America; Department of Psychology, University at Buffalo, Buffalo, New York, United States of America. Electronic address:
Aims: Acute and chronic Δ-THC exposure paradigms affect the body differently. More must be known about the impact of chronic Δ-THC on cannabinoid-1 (CB1R) and mu-opioid (MOR) receptor levels in the brain. The present study examined chronic Δ-THC's effects on CB1R and MOR levels and locomotor activity.
View Article and Find Full Text PDFHistorical Pathways for Opioid Addiction, Withdrawal with Traditional and Alternative Treatment Options with Ketamine, Cannabinoids, and Noribogaine: A Narrative Review.
Health Psychol Res
October 2022
Louisiana Addiction Research Center, Shreveport; Department of Anesthesiology, Louisiana State University Shreveport.
Even as prescription opioid dispensing rates have begun to decrease, the use of illicit opioids such as heroin and fentanyl has increased. Thus, the end of the opioid epidemic is not in sight, and treating patients that are addicted to opioids remains of utmost importance. Currently, the primary pharmacotherapies used to treat opioid addiction over the long term are the opioid antagonist naltrexone, the partial-agonist buprenorphine, and the full agonist methadone.
View Article and Find Full Text PDFIllicit drugs and their metabolites in urban wastewater: Analysis, occurrence and consumption in Xinjiang, China.
Sci Total Environ
December 2022
School of Chemistry and Chemical Engineering/Key Laboratory of Environmental Monitoring and Pollutant Control of Xinjiang Bingtuan, Shihezi University, Shihezi 832003, China.
The use of illicit drugs has increased considerably across the world. Wastewater-based epidemiology (WBE) of illicit drugs might help determine the types and quantity of illicit drugs consumed in a region. In this study, WBE was applied to analyze illicit drugs in five representative urban wastewater treatment plants (WWTPs) in Xinjiang, China.
View Article and Find Full Text PDFMu opioid receptor gene variant modulates subjective response to smoked cannabis.
Am J Transl Res
January 2022
Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, University of Toronto 33 Ursula Franklin Street, Toronto, ON, Canada.
The mu-opioid receptor (MOR) mediates the rewarding properties of many psychoactive drugs and is an important target in the treatment of addictions. Functional interactions between the opioid and endocannabinoid systems are established and have been hypothesized to contribute to the effects of cannabis. We investigated associations between three single nucleotide polymorphisms in the MOR gene (rs1799971, rs2281617, and rs510769) and subjective responses to smoked cannabis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!